罗氏万赛维的价格及规格

(Valganciclovir Hydrochloride Tablets) has previously been approved by the FDA for use in those at high risk of cytomegalovirus (CMV) infection—adult patients who have received kidney transplants. Relevant clinical trial data show that after patients who received kidney transplants were treated with Valcyte, the prevalence of CMV was significantly reduced, and the duration of medication was directly proportional to the efficacy: if the medication was administered for 10Od, the prevalence of CMV was 36.8%; if the medication was administered for 20Od, the prevalence dropped to 16.8%.

The main clinical endpoint of the above-mentioned experiment is to observe the prevalence of CMV within 52 weeks (within 12 months) after the subjects receive kidney transplantation. The secondary endpoints include drug safety, CMV illness time, CMV infection time, acute rejection, transplant kidney failure, etc. Vancevi is currently on the market both at home and abroad, but the prices vary greatly. Patients can purchase drugs based on their own financial capabilities.

In China, the price of Vancevir can be said to be very expensive. One box of it is priced at about $17,000, and the drug specification is 450mg*60 tablets/box. In foreign countries, the Vancevi sold in Türkiye is much cheaper in comparison. According to Medical Companion Travel, a box of the Turkish version of Vancevi is priced at about $3,000, and the drug specification is also 450mg*60 tablets/box, which is relatively cost-effective. Domestic patients who need the Turkish version of Vancevi can either go abroad to purchase it in person or obtain their specific drug purchasing channels through medical companion tours.

Roche is one of the leading biotech companies and a world leader in in vitro diagnostics and tissue-based oncology diagnostics, providing the world with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. The prices developed and produced by Roche vary to a certain extent due to different pricing standards in various countries. Patients can selectively purchase according to their own needs.

Recommended hot articles: /newsDetail/90779.html